Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.21.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Years Ended
December 31,		  
    2020     2019  
Research and development   $ 604,107     $ 915,075  
General and administrative     1,612,209       1,694,295  
Total   $ 2,216,316     $ 2,609,370  
Schedule of stock option activity
                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – January 1, 2019     5,488,282       4,384,294     $ 2.10     $ 1.32     $ 1.32       5.80     $ -  
Granted     2,779,000       -       -       -       -       -       -  
Exercised     (441,210 )     -       -       -       -       -       -  
Cancelled     (193,714 )     -       -       -       -       -       -  
Balance – December 31, 2019     7,632,358       4,542,144     $ 2.21     $ 1.57     $ 1.57       6.44     $ -  
Granted     275,000       -       -       -       -       -       -  
Exercised     (223,924 )     -       -       -       -       -       -  
Cancelled     (213,543 )     -       -       -       -       -       -  
Balance – December 31, 2020     7,469,891       5,390,431     $ 2.06     $ 1.68     $ 1.68       6.27     $ 1,634,719  
Schedule of stock options outstanding and exercisable
Grant Price     Weighted Average     Total     Number   Weighted Average
Remaining
From     To     Exercise Price     Outstanding     Exercisable   Contractual Term
$ 0.26     $ 2.02     $ 0.89       3,119,974     2,935,807   3.48 years
$ 2.10     $ 4.60     $ 2.42       3,756,917     1,914,915   7.76 years
$ 5.30     $ 8.86     $ 6.25       593,000     539,709   7.34 years
                  Totals       7,469,891     5,390,431    
Schedule of warrants activity
                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – January 1, 2019     4,964,205       4,964,205     $ 2.39     $ 2.39     $ 1.14       2.27     $ -  
Granted     -       -       -       -       -       -       -  
Exercised     (50,000 )     -       -       -       -       -       -  
Cancelled     (6,982 )     -       -       -       -       -       -  
Balance – December 31, 2019     4,907,223       4,907,223     $ 2.40     $ 2.40     $ 1.11       1.55     $ 833,793  
Granted     14,485,595       -       -       -       -       -       -  
Exercised     (20,000 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – December 31, 2020     19,372,818       15,495,973     $ 1.62     $ 1.61     $ 0.81       4.07     $ 866,300